WHO ICTRP trial
RESTART
EUCTR2012-003190-26-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-003190-26-GB |
|---|---|
| Public title | RESTART |
| Scientific title | REstart or STop Antithrombotics Randomised Trial (RESTART) - REstart or STop Antithrombotics Randomised Trial (RESTART) |
| Primary sponsor | ACCORD (Academic and Clinical Central Office for Research & Development) |
| Secondary sponsors | ACCORD (Academic and Clinical Central Office for Research & Development) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom |
| Conditions | Spontaneous Intracerebral Haemorrhage (ICH) MedDRA version: 14.1 Level: LLT Classification code 10022753 Term: Intracerebral haemorrhage System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Aspirin Pharmaceutical Form: Product Name: Dipyridamole Pharmaceutical Form: Product Name: Clopidogrel Pharmaceutical Form: |
| Registration date | Nov 26, 2012 |
| Target size | 720 |
| Secondary IDs | RESTART13 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: